NO20031377L - Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese - Google Patents

Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese

Info

Publication number
NO20031377L
NO20031377L NO20031377A NO20031377A NO20031377L NO 20031377 L NO20031377 L NO 20031377L NO 20031377 A NO20031377 A NO 20031377A NO 20031377 A NO20031377 A NO 20031377A NO 20031377 L NO20031377 L NO 20031377L
Authority
NO
Norway
Prior art keywords
angiogenesis
preparation
activator
inhibitor
processes
Prior art date
Application number
NO20031377A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031377D0 (no
Inventor
Andreas Bikfalvi
Gerard Deleris
Natacha Betz
Original Assignee
Univ Bordeaux 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bordeaux 1 filed Critical Univ Bordeaux 1
Publication of NO20031377D0 publication Critical patent/NO20031377D0/no
Publication of NO20031377L publication Critical patent/NO20031377L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20031377A 2000-10-04 2003-03-26 Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese NO20031377L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
PCT/FR2001/003049 WO2002028895A2 (fr) 2000-10-04 2001-10-02 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (2)

Publication Number Publication Date
NO20031377D0 NO20031377D0 (no) 2003-03-26
NO20031377L true NO20031377L (no) 2003-05-02

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031377A NO20031377L (no) 2000-10-04 2003-03-26 Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese

Country Status (15)

Country Link
US (2) USRE44022E1 (de)
EP (1) EP1328546B1 (de)
JP (1) JP4303958B2 (de)
AT (1) ATE354589T1 (de)
AU (2) AU2001293948B2 (de)
CA (1) CA2424506A1 (de)
DE (1) DE60126802T2 (de)
DK (1) DK1328546T3 (de)
ES (1) ES2282293T3 (de)
FR (1) FR2814744B1 (de)
IL (1) IL155117A0 (de)
NO (1) NO20031377L (de)
NZ (1) NZ525069A (de)
RU (1) RU2249599C2 (de)
WO (1) WO2002028895A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
ES2692166T3 (es) * 2003-03-03 2018-11-30 Dyax Corp. Péptidos que se unen específicamente al receptor de HGF (cMet) y usos de los mismos
US20090093016A1 (en) * 2006-01-17 2009-04-09 N.V. Organon Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides
US8227413B2 (en) 2006-10-19 2012-07-24 Ramot At Tel-Aviv University Ltd. Compositions and methods for inducing angiogenesis
US8741850B2 (en) 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
WO2014034922A1 (ja) * 2012-09-03 2014-03-06 国立大学法人東京大学 血管内皮細胞増殖因子受容体阻害ペプチド
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4237456A1 (de) * 1992-11-06 1994-05-11 Merck Patent Gmbh Cyclopeptide
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5939383A (en) * 1996-11-15 1999-08-17 Remacle; Jose Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
EP1056773A2 (de) * 1998-02-11 2000-12-06 Resolution Pharmaceuticals Inc. Für angiogenese spezifische moleküle
AU776473C (en) * 1999-03-11 2005-04-14 Entremed, Inc Compositions and methods for treating cancer and hyperproliferative disorders

Also Published As

Publication number Publication date
EP1328546B1 (de) 2007-02-21
NZ525069A (en) 2004-09-24
EP1328546A2 (de) 2003-07-23
IL155117A0 (en) 2003-10-31
US20040092434A1 (en) 2004-05-13
DK1328546T3 (da) 2007-06-04
CA2424506A1 (en) 2002-04-11
DE60126802T2 (de) 2007-11-08
JP2004510784A (ja) 2004-04-08
WO2002028895A2 (fr) 2002-04-11
AU2001293948B2 (en) 2005-11-03
DE60126802D1 (de) 2007-04-05
USRE44022E1 (en) 2013-02-19
ES2282293T3 (es) 2007-10-16
JP4303958B2 (ja) 2009-07-29
RU2249599C2 (ru) 2005-04-10
ATE354589T1 (de) 2007-03-15
FR2814744A1 (fr) 2002-04-05
WO2002028895A3 (fr) 2002-06-06
NO20031377D0 (no) 2003-03-26
AU9394801A (en) 2002-04-15
US7199100B2 (en) 2007-04-03
FR2814744B1 (fr) 2002-11-29

Similar Documents

Publication Publication Date Title
NO20031377D0 (no) Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese
EE05485B1 (et) Plasmi(i)n(ogeen)i eemaldamine valgulahustest
DK1210430T3 (da) MUC-1-afledte peptider
CO5590973A2 (es) Acido nucleico de adenovirus de simio y secuiencias de aminoacidos, vectores que contienen los mismos y metodos de uso
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
SE9300140D0 (sv) Solid substrate
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
ID16497A (id) Sistem pompa kriogenik
ES2046237T3 (es) Acidos boronicos peptidos inhibidores de proteasas de tipo tripsinico.
PT1165115E (pt) Modulacao da permeabilidade vascular por meio dos activadores do receptor tie2
NO942110L (no) Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav
DK1024822T3 (da) CD8 som inhibitor for det cellulære immunsystem
NO960939D0 (no) Kininogenaseinhibitor
ATE235912T1 (de) Bradikininanaloge als selektive thrombininhibitoren
DE60027030D1 (de) Membrantranslokierendes peptid als wirkstofftransportsystem
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
TR200100430T2 (tr) Tyrosine kinase SRC kullanılan angiogenesisin modülasyonu için yararlı metot ve bileşimler.
NO20055210L (no) Inhibitorproteiner av en protease og anvendelse derav
CO5271650A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia
Teruya et al. Total synthesis of [L40I, C90A, C109A]-human T-cell leukemia virus type 1 protease
NO951277L (no) Desulfatohirudin med höy molekylvekt
EP1362915A4 (de) Aus nomuraea rileyi stammende ecdysteroid-22-oxidase und system zur häutungshormon-inaktivierung damit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application